Advancing Regenerative Science with Purpose
Marine Biomedical is an Australian biotechnology company developing advanced biomaterials to support bone repair and regeneration. By translating insights from nature into clinically relevant technologies, we aim to deliver safe, effective, and sustainable solutions for modern medicine.
Company Overview
Founded in Western Australia, Marine Biomedical was established to bridge marine biomaterials research and medical application. The company’s work centres on the development of PearlBone™ — a nacre-derived biomaterial designed to support bone regeneration.
Marine Biomedical combines multidisciplinary expertise across materials science, biomedical research, and medical manufacturing. Its development programs are guided by preclinical research, regulatory pathways, and partnerships with academic and clinical collaborators.
With a strong focus on translational science, the company is progressing its technologies through defined development milestones, with the goal of supporting future clinical adoption and global commercialisation.
Leadership & Governance
Marine Biomedical is led by an experienced team of scientists, executives, and advisors with backgrounds spanning biomedical research, clinical translation, and regulated medical industries.
Strong governance underpins all company activities, with a clear emphasis on ethical research conduct, quality systems, and regulatory alignment.
News & Media
Stay up to date with Marine Biomedical’s latest developments, research milestones, and media coverage.
